193 related articles for article (PubMed ID: 24637514)
1. Antifungal lock therapy with combined 70% ethanol and micafungin in a critically ill infant.
Piersigilli F; Auriti C; Bersani I; Goffredo B; Bianco G; Savarese I; Dotta A
Pediatr Infect Dis J; 2014 Apr; 33(4):419-20. PubMed ID: 24637514
[TBL] [Abstract][Full Text] [Related]
2. [Could antifungal lock be useful in the management of candidiasis linked with catheters?].
Cateau E; Rodier MH; Imbert C
Med Sci (Paris); 2012; 28(8-9):740-5. PubMed ID: 22920876
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of catheter-associated candidemia without removing the central venous line].
González-Granado LI; Rojo-Conejo P; González-Tomé MI; Ruiz-Contreras J
Enferm Infecc Microbiol Clin; 2010; 28(7):473-4. PubMed ID: 20096971
[No Abstract] [Full Text] [Related]
4. Development of New Strategies for Echinocandins: Progress in Translational Research.
Walsh TJ; Azie N; Andes DR
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S601-3. PubMed ID: 26567276
[TBL] [Abstract][Full Text] [Related]
5. Echinocandin and ethanol lock therapy treatment of fungal catheter infections.
Pieroni KP; Nespor C; Poole RL; Kerner JA; Berquist WE
Pediatr Infect Dis J; 2013 Mar; 32(3):289-91. PubMed ID: 23076381
[TBL] [Abstract][Full Text] [Related]
6. [First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula].
López-Soria LM; Bereciartua E; Santamaría M; Soria LM; Hernández-Almaraz JL; Mularoni A; Nieto J; Montejo M
Rev Iberoam Micol; 2013 Jan; 30(1):69-71. PubMed ID: 22982698
[TBL] [Abstract][Full Text] [Related]
7. Micafungin is more active against Candida albicans biofilms with high metabolic activity.
Marcos-Zambrano LJ; Escribano P; González del Vecchio M; Bouza E; Guinea J
J Antimicrob Chemother; 2014 Nov; 69(11):2984-7. PubMed ID: 24942468
[TBL] [Abstract][Full Text] [Related]
8. Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis.
Paul DiMondi V; Townsend ML; Johnson M; Durkin M
Pharmacotherapy; 2014 Jul; 34(7):e120-7. PubMed ID: 24782326
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin.
Hagiya H; Kajioka H
Intern Med; 2013; 52(18):2139-43. PubMed ID: 24042529
[TBL] [Abstract][Full Text] [Related]
10. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
[TBL] [Abstract][Full Text] [Related]
11. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.
Konuma T; Takahashi S; Kiyuna T; Miharu Y; Suzuki M; Shibata H; Kato S; Takahashi S; Tojo A
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27859978
[TBL] [Abstract][Full Text] [Related]
13. Successful Eradication of Candida Central Venous Catheter Infection With Ambisome Line Lock in Factitious Illness.
Guest T; Ashbee R; Puntis J
J Pediatr Gastroenterol Nutr; 2015 Nov; 61(5):e24. PubMed ID: 26505962
[No Abstract] [Full Text] [Related]
14. Assessment of the anti-biofilm effect of micafungin in an animal model of catheter-related candidemia.
Salinas B; Guembe M; Cussó L; Kestler M; Guinea J; Desco M; Muñoz P; Bouza E
Med Mycol; 2019 Jun; 57(4):496-503. PubMed ID: 30212901
[TBL] [Abstract][Full Text] [Related]
15. Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight.
Li MJ; Hsueh PR; Lu CY; Chou HC; Lee PI; Chang LY; Huang LM
J Formos Med Assoc; 2012 Jan; 111(1):46-50. PubMed ID: 22333013
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ethanol lock therapy in pediatric patients on long-term parenteral nutrition.
Pieroni KP; Nespor C; Ng M; Garcia M; Hurwitz M; Berquist WE; Kerner JA
Nutr Clin Pract; 2013 Apr; 28(2):226-31. PubMed ID: 23232749
[TBL] [Abstract][Full Text] [Related]
17. An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans - Staphyloccoccus aureus Biofilms.
Lown L; Peters BM; Walraven CJ; Noverr MC; Lee SA
PLoS One; 2016; 11(7):e0159225. PubMed ID: 27428310
[TBL] [Abstract][Full Text] [Related]
18. [Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins].
Almirante B; Garnacho-Montero J; Maseda E; Candel FJ; Grau S; Guinea J; Moreno I; Muñoz P; Ruiz-Santana S
Rev Esp Quimioter; 2017 Oct; 30(5):355-367. PubMed ID: 28945064
[TBL] [Abstract][Full Text] [Related]
19. Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia.
Tascini C; Sozio E; Di Paolo A; Tintori G; Leonildi A; Bertolino G; Carmassi F; Tagliaferri E; Menichetti F; Barchiesi F
J Chemother; 2017 Dec; 29(6):376-379. PubMed ID: 28198656
[TBL] [Abstract][Full Text] [Related]
20. [Invasive fungal infection in critically ill patient: role of micafungin].
Nieto Cabrera M; López-Cepero EE
Rev Esp Quimioter; 2012 Mar; 25(1):4-9. PubMed ID: 22488535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
